Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potent protein farnesyltransferase inhibitors emerge from Parke-Davis program

Sep. 3, 1999

Licensing opportunity from NIH: geldanamycins as inhibitors of the HGF/SF-Met pathway

Sep. 3, 1999

IGT-13, a new and improved etoposide analogue enters the IGT pipeline

Sep. 2, 1999

More ACS news: preclinical profile of a novel protein farnesyltransferase inhibitor, Sch-207758

Sep. 2, 1999

New Roche compounds enhance tumor delivery of 5-FU

Sep. 2, 1999

Cytoclonal makes strides in the design of new anticancer compounds

Sep. 2, 1999

Preparation, activity and use of piperidine protein farnesyltransferase inhibitors from LG Chemical

Sep. 2, 1999

Scotia's Foscan achieves positive results in phase III clinical trial

Sep. 1, 1999

New anticancer compound from Diatide shown to arrest tumor growth

Sep. 1, 1999

Progen receives provisional approval to undertake clinical studies of PI-88 at second site

Sep. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026